Arpraziquantel for schistosomiasis in young children
Part of Infections clinical trials.
This study tests a new medicine called arpraziquantel to treat schistosomiasis (a disease from parasites in water) in young children aged 2 to 5. It aims to see if giving this treatment in communities where the disease is common is safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lived in the study area for at least 6 months.
- Your child is between 2 and 5 years old (24 to 59 months).
- You or your child’s guardian give permission (informed consent).
- Your child does not have a serious illness or trouble taking medicine by mouth.
- Your child has never had a seizure.
- Your child is not allergic to praziquantel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different schedules of the drug praziquantel to see which works better for treating liver scarring caused by a parasitic infection called schistosomiasis. It aims to improve liver health and prevent complications.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This trial looks at how active a long-term schistosomiasis infection is in travelers and migrants. It aims to better understand the infection to help guide treatment.
This study aims to identify the types of schistosomiasis (a parasitic infection) in patients in Assiut Governorate. It involves testing urine or stool samples to confirm the infection.
This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.
This trial tests giving school-age children a short course of medicine to prevent malaria and see if it can reduce the spread of the disease in the community. It involves taking pills at set times during the school year.
Hear when a new Schistosomiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.